Last updated: 27 January 2022 at 5:28pm EST

Advisors Llc Orbi Med Capit... Net Worth




The estimated Net Worth of Advisors Llc Orbi Med Capit... is at least $42.1 Million dollars as of 25 January 2022. Advisors Capit owns over 70,573 units of 89bio Inc stock worth over $14,836,726 and over the last 6 years Advisors sold ETNB stock worth over $27,230,142.

Advisors Capit ETNB stock SEC Form 4 insiders trading

Advisors has made over 5 trades of the 89bio Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Advisors sold 70,573 units of ETNB stock worth $592,107 on 25 January 2022.

The largest trade Advisors's ever made was selling 4,246,196 units of 89bio Inc stock on 30 August 2018 worth over $18,938,034. On average, Advisors trades about 1,323,854 units every 249 days since 2018. As of 25 January 2022 Advisors still owns at least 1,829,436 units of 89bio Inc stock.

You can see the complete history of Advisors Capit stock trades at the bottom of the page.



What's Advisors Capit's mailing address?

Advisors's mailing address filed with the SEC is 601 Lexington Ave, New York, NY 10022, USA.

Insiders trading at 89bio Inc

Over the last 5 years, insiders at 89bio Inc have traded over $17,267,666 worth of 89bio Inc stock and bought 14,519,952 units worth $208,678,684 . The most active insiders traders include Capital Management, L.P.Ra ..., Capital Management, L.P.Ra ..., and Advisors Llc Orbi Med Capit.... On average, 89bio Inc executives and independent directors trade stock every 28 days with the average trade being worth of $2,197,340. The most recent stock trade was executed by Rohan Palekar on 1 April 2024, trading 52,718 units of ETNB stock currently worth $575,153.



What does 89bio Inc do?

89bio, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. its lead product candidate is bio89-100, a glycopegylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. the company also intends to develop bio89-100 for the treatment of severe hypertriglyceridemia. 89bio, inc. was founded in 2018 and is based in san francisco, california.



What does 89bio Inc's logo look like?

89bio Inc logo

Complete history of Advisors Capit stock trades at ContextLogic Inc and 89bio Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
25 Jan 2022 Advisors Llc Orbi Med Capit...
Sale 70,573 $8.39 $592,107
25 Jan 2022
1,829,436
21 Sep 2020 Advisors Llc Orbi Med Capit...
Sale 275,000 $28.00 $7,700,000
21 Sep 2020
1,864,721
11 Nov 2019 Advisors Llc Orbi Med Capit...
Buy 837,500 $16.00 $13,400,000
11 Nov 2019
724,363
23 Oct 2018 Advisors Llc Orbi Med Capit...
Buy 1,190,000 $10.00 $11,900,000
23 Oct 2018
6,466,783


89bio Inc executives and stock owners

89bio Inc executives and other stock owners filed with the SEC include: